Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats. (Q46582056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sadayoshi Itō

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Byung Ha Chung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Bo Kyung Sun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sun Woo Lim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Kyung Ohk Ahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Ji Hun Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Yoon Hee Choi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Kun Ho Yoon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Akira Sugawara

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Jin Kim

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Chul Woo Yang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

1856-1867

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15996232%20AND%20SRC:MED&resulttype=core&format=json

Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Rosiglitazone restores G-protein coupling, recruitment, and function of renal dopamine D1A receptor in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Peroxisome proliferator-activated receptors and cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Effects of mitogen-activated protein kinase pathway and co-activator CREP-binding protein on peroxisome proliferator-activated receptor-gamma-mediated transcription suppression of angiotensin II type 1 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Rosiglitazone treatment of diabetes mellitus after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X

Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00979.X